This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dsm IP Assets B.v.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Jelena Hyppönen
Introduction
Jelena Hyppönen is a prominent inventor based in Kuopio, Finland. She has made significant contributions to the field of genetics, particularly in relation to type 2 diabetes and obesity. Her work focuses on understanding the genetic factors that contribute to these conditions and developing methods for diagnosis and treatment.
Latest Patents
Jelena Hyppönen holds a patent related to "Genes and markers in type 2 diabetes and obesity." This patent discloses genes, SNP markers, and haplotypes that are associated with susceptibility or predisposition to type 2 diabetes (T2D) and related medical conditions. The patent also outlines methods for diagnosing and predicting the clinical course of T2D, as well as the efficacy of treatments for T2D and obesity. Additionally, it provides kits for diagnosis, treatment selection, and prognosis assessment of T2D. The novel methods disclosed in her patent aim to prevent and treat metabolic diseases based on the identified T2D genes and related pathways.
Career Highlights
Jelena Hyppönen is associated with Dsm IP Assets B.V., where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on public health, particularly in managing and preventing metabolic diseases.
Collaborations
Throughout her career, Jelena has collaborated with notable colleagues, including Jukka T. Salonen and Jari Kaikkonen. These collaborations have further enriched her research and contributed to the development of innovative solutions in her field.
Conclusion
Jelena Hyppönen's contributions to the understanding of genetic factors in type 2 diabetes and obesity highlight her role as an influential inventor. Her patent and ongoing research have the potential to significantly impact the diagnosis and treatment of these prevalent health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
